About Transcatheter Technologies
Transcatheter Technologies is a company based in Regensburg (Germany) founded in 2009 was acquired by Venus MedTech in April 2016.. Transcatheter Technologies has raised $6.7 million across 4 funding rounds from investors including Venus MedTech, KfW and High-Tech Gründerfonds. Transcatheter Technologies operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others.
- Headquarter Regensburg, Germany
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$6.7 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Venus MedTech
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Venus MedTech
(Apr 18, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Transcatheter Technologies
Transcatheter Technologies has successfully raised a total of $6.7M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(13 Jul 2009)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2014 | Amount | Series B - Transcatheter Technologies | Valuation |
investors |
|
| Mar, 2013 | Amount | Series B - Transcatheter Technologies | Valuation |
investors |
|
| May, 2011 | Amount | Series A - Transcatheter Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Transcatheter Technologies
Transcatheter Technologies has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Venus MedTech, KfW and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
High-tech industries are targeted for investments by Bayern Kapital.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Transcatheter Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Transcatheter Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transcatheter Technologies Comparisons
Competitors of Transcatheter Technologies
Transcatheter Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Symetis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| domain | founded_year | HQ Location |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| domain | founded_year | HQ Location |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Minimally invasive heart valve replacement devices are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Transcatheter Technologies
When was Transcatheter Technologies founded?
Transcatheter Technologies was founded in 2009.
Where is Transcatheter Technologies located?
Transcatheter Technologies is headquartered in Regensburg, Germany. It is registered at Regensburg, Bavaria, Germany.
Is Transcatheter Technologies a funded company?
Transcatheter Technologies is a funded company, having raised a total of $6.7M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.52M, raised on Jul 13, 2009.
What does Transcatheter Technologies do?
Transcatheter Technologies is a medical device company specializing in catheter-based heart valve implantation and aortic therapy. Key products in development are the transcatheter aortic valve implantation system TRINITY, the transcatheter mitral valve implant TRESILLO and the endovascular aortic repair stent TUMBAO.
Who are the top competitors of Transcatheter Technologies?
Transcatheter Technologies's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Who are Transcatheter Technologies's investors?
Transcatheter Technologies has 5 investors. Key investors include Venus MedTech, KfW, High-Tech Gründerfonds, Tubaflex, and Bayern Kapital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.